Abstract

BackgroundInterstitial pneumonia (IP) may precede the clinical onset of connective tissue diseases (CTD). Idiopathic pulmonary fibrosis (IPF) is fibrosing pneumonia of an unknown cause, and has a poor prognosis. The...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease.
Helen E Jo ... Tamera J Corte
Respirology (Carlton, Vic.) | VOL. 21
Helen E Jo, et. al.Helen E Jo ... Tamera J Corte
24 Feb 2016
Computer-aided Quantification of Pulmonary Fibrosis in Patients with Lung Cancer: Relationship to Disease-free Survival.
Michihiko Tajiri ... Takashi Ogura
Radiology | VOL. 292
Michihiko Tajiri, et. al.Michihiko Tajiri ... Takashi Ogura
04 Jun 2019
Inter- and intraobserver variation between radiologists in the detection of abnormal parenchymal lung changes on high-resolution computed tomography
Osama Al-Saeed ... Prio N Sada
Annals of Saudi Medicine | VOL. 30
Osama Al-Saeed, et. al.Osama Al-Saeed ... Prio N Sada
01 Mar 2010
Interstitial Lung Diseases Associated with Connective Tissue Pathologies: Radiologic Features
Houda Gharsalli ... Monia Attia
Open Journal of Respiratory Diseases | VOL. 09
Houda Gharsalli, et. al.Houda Gharsalli ... Monia Attia
01 Jan 2019
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers